ClinVar Miner

Submissions for variant NM_172056.2(KCNH2):c.1886A>C (p.Asn629Thr) (rs199472957)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000413164 SCV000490551 pathogenic not provided 2015-08-10 criteria provided, single submitter clinical testing The N629T pathogenic variant in the KCNH2 gene has been reported in one individual of European ancestry who was diagnosed with LQTS at the age of 3 years and had a family history of a first degree relative with sudden death before the age of 35 years (Chung S et al., 2007). N629T results in a conservative amino acid substitution at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Moreover, pathogenic variants affecting this same residue, (N629S, N629I, N629K, N629D) and nearby residues (G628R, G628A, G628S, G628V, V630A, V630L) in the highly conserved pore region have been reported in the Human Gene Mutation Database in association with LQTS (Stenson P et al., 2014), further supporting the functional importance of this residue and this region of the protein. Furthermore, N629T was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. In summary, N629T in the KCNH2 gene is interpreted as a pathogenic variant.
Invitae RCV000475088 SCV000543415 likely pathogenic Long QT syndrome 2016-07-31 criteria provided, single submitter clinical testing This sequence change replaces asparagine with threonine at codon 629 of the KCNH2 protein (p.Asn629Thr). The asparagine residue is highly conserved and there is a small physicochemical difference between asparagine and threonine. This variant is not present in population databases (ExAC no frequency). This variant has been reported in one individual affected with long QT syndrome (PMID: 17905336). ClinVar contains an entry for this variant (Variation ID: 67314). Other missense substitutions at this codon (p.Asn629Asp, p.Asn629Ser, p.Asn629Ile, p.Asn629Lys) have been determined to be pathogenic (PMID: 10973849, 16432067, 19841300, 25417810). This suggests that the asparagine residue is critical for KCNH2 protein function and that other missense substitutions at this position may also be pathogenic. This variant identified in the KCNH2 gene is located in the pore region of the resulting protein (PMID: 19841300, 25348405). Experimental studies have shown that it alters the properties of the channel (PMID: 22573844). For these reasons, this variant has been classified as Likely Pathogenic.
Cardiovascular Biomedical Research Unit,Royal Brompton & Harefield NHS Foundation Trust RCV000058033 SCV000089553 not provided Congenital long QT syndrome no assertion provided literature only This variant has been reported as associated with Long QT syndrome in the following publications (PMID:17905336). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.